Search
Zoetis Inc
ZTSAdd to Watchlist
78.710USD
+1.420+1.84%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
33.45BMarket Cap
13.03P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Zoetis Inc is 7.80, ranking 94 out of 157 in the Pharmaceuticals industry. The average price target is 165.00, with a high of 200.00 and a low of 130.00.
Analyst Rating
Based on
20
analysts
Buy
Current Rating
125.941
Target Price
+63.01%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Zoetis Inc
ZTS
20
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Zoetis Inc's expected revenue for the next quarter?
Zoetis Inc's expected revenue is 2.50B.
What is Zoetis Inc's price target?
Analysts forecast that Zoetis Inc's price target is USD 165.00, with the highest forecast at USD 200.00 and the lowest forecast at USD 130.00.
How have Zoetis IncZTS's recent earnings per share performed?
The market expectation was USD 1.42, while Zoetis IncZTS's earnings per share (EPS) for the previous quarter was USD 1.38. EPS for the next quarter is expected at USD 1.86.
What is the analyst rating for Zoetis Inc?
Based on the ratings of Zoetis Inc's stock from 20 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
